Loading...

Ironwood Pharmaceuticals, Inc.

IRWD•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$3.93
$0.14(3.69%)
U.S. Market opens in NaNh NaNm

Ironwood Pharmaceuticals, Inc. (IRWD) Stock Overview

Explore Ironwood Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap640.8M
P/E Ratio26.34
EPS (TTM)$0.15
ROE-0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$3.13
3 Months$4.27
1 Year Target$1.12

IRWD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ironwood Pharmaceuticals, Inc. (IRWD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.45, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.12.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 26.34 and a market capitalization of 640.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.69%
5-Day Change
-11.69%
1-Month Change
29.28%
3-Month Change
-24.86%
6-Month Change
136.75%
Year-to-Date (YTD) Change
16.62%
1-Year Change
347.25%
3-Year Change
-62.82%
5-Year Change
-64.91%
All-Time (Max) Change
-66.27%

Contact Information

https://www.ironwoodpharma.com
617 621 7722
100 Summer Street, Boston, MA, 02110

Company Facts

253 Employees
IPO DateFeb 3, 2010
CountryUS
Actively Trading

Frequently Asked Questions